acetylcysteine and Epidermolysis Bullosa

acetylcysteine has been researched along with Epidermolysis Bullosa in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Aguado, T; Botella, LM; Del Río, M; Ferrer-Mayorga, G; García, A; García, M; Martínez-Santamaría, L; Sánchez-Puelles, JM	1

Other Studies

1 other study(ies) available for acetylcysteine and Epidermolysis Bullosa

Article	Year
Raloxifene and n-Acetylcysteine Ameliorate TGF-Signalling in Fibroblasts from Patients with Recessive Dominant Epidermolysis Bullosa. Cells, 2020, 09-16, Volume: 9, Issue:9 Topics: Acetylcysteine; Activin Receptors, Type II; Antioxidants; Case-Control Studies; Collagen Type VII; Drug Repositioning; Endoglin; Epidermolysis Bullosa; Estrogen Antagonists; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Gene Expression Regulation; Humans; Inheritance Patterns; Primary Cell Culture; Raloxifene Hydrochloride; Receptor, Transforming Growth Factor-beta Type I; Severity of Illness Index; Signal Transduction; Skin; Smad Proteins; Transforming Growth Factor beta1	2020

Article

Year

Raloxifene and n-Acetylcysteine Ameliorate TGF-Signalling in Fibroblasts from Patients with Recessive Dominant Epidermolysis Bullosa.

Cells, 2020, 09-16, Volume: 9, Issue:9

Topics: Acetylcysteine; Activin Receptors, Type II; Antioxidants; Case-Control Studies; Collagen Type VII; Drug Repositioning; Endoglin; Epidermolysis Bullosa; Estrogen Antagonists; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Gene Expression Regulation; Humans; Inheritance Patterns; Primary Cell Culture; Raloxifene Hydrochloride; Receptor, Transforming Growth Factor-beta Type I; Severity of Illness Index; Signal Transduction; Skin; Smad Proteins; Transforming Growth Factor beta1

2020